TDM 검사 신빙도조사 결과보고(2000)

초록

Two trials of external quality assessment for Therapeutic Drug Monitoring (TDM) were performed in 2000. A total of two specimens were distributed. One specimen was distributed to 82 laboratories with 75 response (91.4%) in the first trial and the other specimen to 82 laboratories with 71 response (86.6%) in the second trial. In the first trial, 26 test items including acetaminophen, amikacin, amitriptyline, carbamazepine, chloramphenicol, cyclosporine, digoxin, disopyramide, ethosuximide, free phenytoin, gentamicin, lidocaine, lithium, methotrexate, N-acetyl-procainamide, phenobarbital, phenytoin, primidone, procainamide, propranolol, quinidine, salicylate, theophylline, tobramycin, valproic acid, and vancomycin were evaluated. In the second trial, 17 items excluding amitriptyline, chloramphenicol, cyclosporine, disopyramide, free phenytoin, lidocaine, lithium, methotrexate, and propranolol were evaluated. The results of the two trials in 2000 were summarized as follows.

키워드